I agree that this site is using cookies. You can find further informations here.
X
Jairath, V.
238  results:
?
1

OC.13.2: EARLY HISTO-ENDOSCOPIC RESPONSE PREDICTS CLINICAL ..:

Magro, F. ; Pai, R.K. ; Kobayashi, T....
Digestive and Liver Disease.  56 (2024)  - p. S193 , 2024
Link: https://doi.org/10.1016/..
 
?
2

P901 Extended induction response over time in patients with..:

Rubin, D T ; Charabaty, A ; Jairath, V...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1651-i1652 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P879 Comparative Efficacy of Biologics and Small Molecule T..:

Shehab, M ; Alrashed, F ; Alsayegh, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1621-i1621 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Editorial: Sonographic assessment of colonic content—A new ..:

Mathias, R. M. ; Chu, M. K. W. ; Edwards, S....
Alimentary Pharmacology & Therapeutics.  60 (2024)  2 - p. 296-297 , 2024
Link: https://doi.org/10.1111/..
 
?
5

P280 Comparative responsiveness of disease activity indices..:

Solitano, V ; Panaccione, R ; Sands, B E...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i647-i648 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P1013 Placebo rates in Crohn's disease: An individual patie..:

Solitano, V ; Hogan, M ; Singh, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1830-i1832 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P696 Initiation of Vedolizumab did not provoke new-onset sp..:

Rohekar, S ; Boyd, T ; Lambert, R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1318-i1318 , 2024
Link: https://doi.org/10.1093/..
 
?
8

A297 EXAMINING THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN ..:

Malhi, G ; Diaz, L A ; Punchhi, G...
Journal of the Canadian Association of Gastroenterology.  7 (2024)  Supplement_1 - p. 240-242 , 2024
Link: https://doi.org/10.1093/..
 
?
9

Meta‐analysis: Intestinal ultrasound to evaluate colonic co..:

Mathias, R. M. ; Chu, M. K. W. ; Edwards, S....
Alimentary Pharmacology & Therapeutics.  60 (2024)  1 - p. 6-16 , 2024
Link: https://doi.org/10.1111/..
 
?
10

P501 Communicating Needs and Features of IBD Experiences (C..:

Jairath, V ; Glass, J ; Braun, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i996-i998 , 2024
Link: https://doi.org/10.1093/..
 
?
11

OP05 Primary efficacy and safety of mirikizumab in moderate..:

Ferrante, M ; Danese, S ; Chen, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i7-i9 , 2024
Link: https://doi.org/10.1093/..
 
?
12

OP35 Efficacy of mirikizumab in comparison to ustekinumab i..:

Jairath, V ; Sands, B E ; Bossuyt, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i62-i64 , 2024
Link: https://doi.org/10.1093/..
 
?
13

P550 Short and long-term outcomes after acute severe ulcera..:

Vuyyuru, S ; Alphonsus, L ; De Silva, T A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1082-i1083 , 2024
Link: https://doi.org/10.1093/..
 
?
14

OP40 Transcriptomic signature of response to vedolizumab in..:

Linggi, B ; Salas, A ; Veny, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i71-i71 , 2024
Link: https://doi.org/10.1093/..
 
?
15

P932 Corticosteroid-sparing effect of mirikizumab for the t..:

Laharie, D ; Siegel, C ; Dulai, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1697-i1698 , 2024
Link: https://doi.org/10.1093/..
 
1-15